2McGuire S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press, 2015[J]. Adv Nutr, 2016, 7(2) : 418-419.
3Chen W, Zheng R, Baade PD, et al. J. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
4Sanchez-Salcedo P, Zulueta JJ. Lung cancer in chronic obstructive pulmonary disease patients, it is not just the cigarette smoke [ J ]. Curr Opin Pulm Med, 2016, 22(4) : 344-349.
5Schwartz AG, Cote ML. Epidemiology of Lung cancer[J]. Adv Exp Med Biol, 2016, 893: 21-41.
6Tessema M, Yingling CM, Picchi MA, et al. Epigenetic repression of CCDC37 and MAP1B links chronic obstructive pulmonary disease to lung cancer[J].J Thorac Onco, 2015, 10(8) : 1181-1188.
7Hu H, Zhang L, Teng G, et al. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-Tg and contributes to the development of lung cancer in patients with COPD[ J]. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1641-1649.
8Yang L, Lu X, Qiu F, Fang W, et al. Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer[ J]. Eur J Hum Genet, 2015, 23(8) : 1019-1024.
9Plywaczewski R, Maciejewski J, Bednarek M, et al. Causes of deaths in COPD patients in primary care setting-a 6-year follow-up [ J 1. Pneumonol Alergol Pol, 2015, 83(3) : 193-202.
10Chiang CL, Hu YW, Wu CH, et al. Spectrum of cancer risk among Taiwan Residents with chronic obstructive pulmonary disease [ J ]. Int J Clin Oncol, 2016, 21(5): 1014-1020.
